focus -WSS

focus

author：leisure time 2025-09-30 12:10:43 - browse：2164

Illumina, the leading maker of DNA sequencing machines, said Sunday that it would divest Grail, the developer of a multi-cancer screening test, which it bought over the objections of regulators in the U.S. and Europe in August 2021.

Illumina said the decision to spin Grail off followed a Friday decision of the U.S. Fifth Circuit Court of Appeals, which held that the merger was anti-competitive. It said that it would divest Grail either by selling it to another company or listing it on capital markets, consistent with an order from the European Commission, and that it aims to finalize the terms of the deal by the end of the second quarter of 2024.

The decision opens what should be the final chapter in one of the most disastrous attempted mergers in biotech history. Illumina, a storied name that had delivered investors strong returns over two decades, spun out Grail in 2016 in order to raise money to fund the company’s work. Then, it announced plans to re-acquire the firm for $7.1 billion in Sept. 2020.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： BIO selects John Crowley as new CEO

WSS

Medicare explains how it will choose drugs for negotiation

Organ aging and disease risk measured by new blood test

Radiation, mainstay of cancer treatment, begins a fade

How to pay for weight loss drugs and save Medicare

How to make AI work for medicine

Will the market for weight loss drugs really reach $100 billion?

Wikipedia

focus

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

How to make AI work for medicine

Medical leaders decry Supreme Court decision on affirmative action

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Duchenne breakthrough therapy leaves behind pioneering families

Medicare explains how it will choose drugs for negotiation

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How a symptom of dementia informs our understanding of creativity

Tori Bowie and the unacceptable rates of Black maternal death

With clinical trial data readouts, here's how to spot spin

knowledge

2024 GOP presidential candidates spar over abortion in debate

FDA investigates CAR

2024 GOP presidential candidates spar over abortion in debate

30 years of 'Listening to Prozac'

Appeals court upholds limits to abortion pill

Departing Stanford president retracts two papers

leisure time

knowledge

Wikipedia

explore